Skip to main content

Creative Planning

Position in NBIX — Neurocrine Biosciences Inc

CIK 1540235 OVERLAND PARK, KS

Position in NBIX

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$9,009,303
+$1,454,587 QoQ
Shares Held
68,387
+28.4% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0.1476888882389928.ToString("F0")% Shared 0.ToString("F0")% None 99.85231111176101.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Derivatives in NBIX

reported options exposure · as of Jun 30, 2020
CallValue
$12,200
CallShares
100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Creative Planning holds $105,843,094 across 40 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (8.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 NBIX
Neurocrine Biosciences Inc
This page
68,387 $9,009,303

All Filings in NBIX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $9,009,303 68,387
2025-12-31 $7,554,716 53,266
2025-09-30 $4,557,576 32,466
2025-06-30 $1,790,453 14,245
2025-03-31 $1,197,023 10,823
2024-12-31 $2,659,565 19,484
2024-09-30 $1,497,744 12,999
2024-06-30 $1,593,253 11,573
2024-03-31 $1,592,009 11,543
2023-12-31 $1,279,915 9,714
2023-09-30 $929,474 8,262
2023-06-30 $699,799 7,421
2023-03-31 $761,376 7,522
2022-12-31 $813,864 6,814
2022-09-30 $775,970 7,306
2022-06-30 $501,242 5,142
2022-03-31 $378,750 4,040
2021-12-31 $345,449 4,056
2021-09-30 $376,734 3,928
2021-06-30 $355,218 3,650
2021-03-31 $380,344 3,911
2020-12-31 $604,334 6,305
2020-09-30 $579,171 6,023
2020-06-30 $678,808 5,564
2020-06-30 $12,200 100
2020-03-31 $470,745 5,439